Figure 4
Combined resolution rate with 95% CIs of studies of initial treatment with ceftazidime plus a glycopeptide compared to a glycopeptide plus an aminoglycoside.
Figure 4 | BMC Infectious Diseases
Combined resolution rate with 95% CIs of studies of initial treatment with ceftazidime plus a glycopeptide compared to a glycopeptide plus an aminoglycoside.